Cargando…
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
Ovarian cancer is the most lethal gynecological malignancy with high recurrence rates and low survival rates, remaining a disease of high unmet need. Cancer immunotherapy, which harnesses the potential of the immune system to attack tumors, has emerged as one of the most promising treatment options...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141030/ https://www.ncbi.nlm.nih.gov/pubmed/32274314 http://dx.doi.org/10.1002/advs.201903301 |